David Seiter, FNP-C, shares a patient success story involving a teenage patient with severe atopic dermatitis that achieved complete skin...
Leonardo Tjahjono, MD, FAAD, a clinical dermatologist at George Washington University in Washington, DC, discusses dosing regimens for spesolimab (Spevigo)...
Boni Elewski, MD, a professor and chair of dermatology at the University of Alabama in Birmingham, Alabama, discusses the characteristics...
Angela Lamb, MD, an associate professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York,...
Tristan Hasbargen, PA-C, a physician assistant at Dermatology Associates of Tallahassee in Tallahassee, Florida, discusses the treatment of vitiligo, emphasizing...
Ted Lain, MD, MBA, a board-certified dermatologist at Sanova Dermatology in Austin, Texas, discusses the randomized phase 3 THRIVE-AA1 trial...
Leon Kircik, MD, a board-certified dermatologist at the Icahn School of Medicine at Mount Sinai in New York, New York,...
Dr. Cotter, a board-certified dermatologist at Las Vegas Dermatology, presents a real-world case of Prurigo Nodularis, highlighting both the severity...
James Del Rosso, DO, and David Cotter, MD, PhD: Clinical Management of Conjunctivitis, Erythema, and Arthralgia in AD
James Del Rosso, DO: JCAD March 2026 Issue Highlights
Ted Lain, MD, MBA: Long-Term Results of Deuruxolitinib for Alopecia Areata
James Del Rosso, DO: JCAD February 2026 Issue Highlights
Amy McMichael, MD: Eight-Week Outcomes With Deuruxolitinib in Alopecia Areata
